144 (Dutrebis lamivudine 150 mg / raltegravir 300 mg)
Generic Name: lamivudine/raltegravir
Pill imprint 144 has been identified as Dutrebis lamivudine 150 mg / raltegravir 300 mg.
Dutrebis is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Dutrebis lamivudine 150 mg / raltegravir 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- lamivudine 150 mg / raltegravir 300 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antiviral combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Merck & Co., Inc.
More about Dutrebis (lamivudine / raltegravir)
- Side Effects
- Drug Interactions
- Support Group
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: antiviral combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.